Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05HJF
|
|||
| Drug Name |
Boronic acid derivative 5
|
|||
| Synonyms |
PMID26413912-Compound-62
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
INFINITY PHARMACEUTICALS, INC. CASTRO, Alfredo, C. GROGAN, Michael, J. SNYDER, Daniel, A
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H16BNO3
|
|||
| Canonical SMILES |
B(C1=CC2=C(C=C1)C(=O)N(C2)CCC3=CC=CC=C3)(O)O
|
|||
| InChI |
1S/C16H16BNO3/c19-16-15-7-6-14(17(20)21)10-13(15)11-18(16)9-8-12-4-2-1-3-5-12/h1-7,10,20-21H,8-9,11H2
|
|||
| InChIKey |
OWKXCKRUGQYZKS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.